Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
EBIT Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -27.45-8.272.0011.90-5.32

What is the latest EBIT Growth ratio of MEDICAMEN BIOTECH ?

The latest EBIT Growth ratio of MEDICAMEN BIOTECH is -27.45 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-27.45
Mar2024-8.27
Mar20232.00
Mar202211.90
Mar2021-5.32

How is EBIT Growth of MEDICAMEN BIOTECH Trending?

Years EBIT Growth % Change
Mar2025 -27.45
Negative
Mar2024 -8.27
Negative
Mar2023 2
-83.19
Mar2022 11.9
Positive
Mar2021 -5.32 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare EBIT Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹478.7 Cr -4.2% 15.7% -26.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,822.0 Cr 1.6% 8.2% -8.8% Stock Analytics
DIVIS LABORATORIES ₹172,811.0 Cr -0.8% 14.4% 12.2% Stock Analytics
CIPLA ₹127,688.0 Cr -3.9% 5.5% 5.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,840.0 Cr -0.5% 1% 7.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,544.0 Cr -2.1% -0% -2% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-4.2%

15.7%

-26.9%

SENSEX

0.7%

4.7%

6.1%


You may also like the below Video Courses